Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
NASA unveils close-up pictures of the comet popping by from another star - 2Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
- 3Father and son spending Christmas together after health scares
- 4The Significance of Health Projects in Senior Protection.
- 5Who plays Moana in the live-action remake? What to know about Catherine Lagaʻaia.
- 37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- Instructions to Pick the Right Dental Embed Trained professional: An Exhaustive Aide
- The most effective method to Go with Informed Choices on Vehicle Leases
- French lawmakers narrowly approve health care budget, suspending Macron's flagship pension reform
- If evolution is real, then why isn’t it happening now? An anthropologist explains that humans actually are still evolving
- The Electric Bicycle Americans Can Confide in 2024
- Figure out How to Alter Your Volvo XC40 for Further developed Solace
- 6 Exercises to Anticipate in 2024
- Nikki Glaser returns as host of the 2026 Golden Globes: Everything the comedian has said about the upcoming awards show
